Precigen, Inc. (PGEN)
NASDAQ·Healthcare·Biotechnology
$7.48
-5.20%
Mkt Cap $2.65B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (3 analysts)
$14.00
Range $14.00 – $14.00
Implied Upside
+87.2%
Consensus $14.00 vs current $7.48
NASDAQ·Healthcare·Biotechnology
$7.48
-5.20%
Mkt Cap $2.65B
Buy
4
Hold
0
Sell
0
Price Target (3 analysts)
$14.00
Range $14.00 – $14.00
+87.2%
Consensus $14.00 vs current $7.48